Pfizer Inc
Saudi Arabia goes massive in Davos as it looks to come to be a prime AI tech hub for the Middle East
A pop-up showcasing Saudi Arabia’s Neom development options among the the most notable on the Davos promenade in 2024. CNBC DAVOS, Switzerland — For years, the United Arab Emirates has been the Middle East’s go-to tech hub, many thanks partly to its lack of individual profits tax, versatile visa guidelines, and competitive incentives for global […]
Read More
OpenAI's Altman suggests U.S. and AI will be ɿine' no make any difference who wins White Dwelling after Trump's Iowa landslide
Sam Altman, main government officer of OpenAI, at the Hope International Forums annual conference in Atlanta, Georgia, US, on Monday, Dec. 11, 2023. Dustin Chambers | Bloomberg | Getty Images DAVOS, Switzerland — OpenAI founder and CEO Sam Altman said generative artificial intelligence as a sector, and the U.S. as a state are both “likely […]
Read More
OpenAI CEO Sam Altman suggests ChatGPT doesn't need New York Times details amid lawsuit
Sam Altman, CEO of OpenAI, at the Hope World wide Forums once-a-year conference in Atlanta on Dec. 11, 2023. Dustin Chambers | Bloomberg | Getty Photos DAVOS, Switzerland — Sam Altman claimed he was ‘surprised’ by the New York Times’ lawsuit towards his organization OpenAI, declaring its synthetic intelligence models failed to want to teach […]
Read More
The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. Michael Siluk | UCG | Getty Images Drugmakers have been scrambling to join a two-horse race to lead the market for popular weight loss drugs, which could […]
Read More
Jamie Dimon claims he's done conversing about bitcoin: ‘I don't care’
DAVOS, Switzerland — Bitcoin does very little, JPMorgan Chase CEO Jamie Dimon stated Wednesday on the sidelines of the Earth Economic Discussion board. “I simply call it the pet rock,” he extra. Dimon is a extended-time bitcoin critic. The bank main said in 2021 at peak crypto valuations that bitcoin was “worthless,” and he doubled down on […]
Read More
Generative AI dominates Davos discussions as companies emphasis on accuracy
Sam Altman, chief govt officer of OpenAI, at the Hope International Message boards once-a-year meeting in Atlanta, Georgia, US, on Monday, Dec. 11, 2023. Dustin Chambers | Bloomberg | Getty Images DAVOS, Switzerland — The increase of generative artificial intelligence has dominated private and general public dialogue at the Entire world Economic Forum as the […]
Read More
4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured so much of the growth as Abbott Labs , […]
Read More
Heading to Davos, right here's what was overheard on connecting trains from Zurich to the World Economic Forum
Zurich’s principal coach station MacKenzie Sigalos DAVOS, Switzerland — It took 18 hours, a Lyft, two planes, three cross-nation practice rides, and a drive in a Volvo athletics utility car to get from midtown Manhattan to an apartment on Scalettastrasse, a snow-lined avenue in the coronary heart of Davos. The compact Swiss Alpine town is […]
Read More
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead. […]
Read More
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment. […]
Read More